Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study.
about
The potential role of incretin therapy in the hospital setting.Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K Study.Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized PatientsStandardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different WardsInpatient Use of Computer-Guided Insulin Devices Moving into the Non-Intensive Care Unit SettingManagement of Hyperglycemia and Diabetes in Orthopedic Surgery.Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients.The use of non-insulin anti-diabetic agents to improve glycemia without hypoglycemia in the hospital setting: focus on incretins.Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes.Sitagliptin for Type 2 diabetes: a 2015 update.Cardiovascular Safety of Antidiabetic Drugs in the Hospital Setting.Hyperglycemia and Diabetes Mellitus Following Organ Transplantation.SGLT2-I in the Hospital Setting: Diabetic Ketoacidosis and Other Benefits and Concerns.The Emory University Perioperative Algorithm for the Management of Hyperglycemia and Diabetes in Non-cardiac Surgery Patients.A Mobile Computerized Decision Support System to Prevent Hypoglycemia in Hospitalized Patients With Type 2 Diabetes Mellitus.Management of hyperglycemia in the neurosurgery patient.A practical and evidence-based approach to management of inpatient diabetes in non-critically ill patients and special clinical populations.Update on inpatient diabetes management: call for action.Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients.Inpatient hyperglycemia: Clinical management needs in teaching hospital.Perioperative Management of Patients with Diabetes.Peri-operative management of patients with type-2 diabetes mellitus undergoing non-cardiac surgery using liraglutide, glucose-insulin-potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial.Bridging technology and clinical practice: innovating inpatient hyperglycaemia management in non-critical care settings.A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-Term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.Inpatient glucocorticoid use: beneficence vs non-maleficence.Perioperative Hyperglycemia Management: An Update.Update on Glucose Management Among Noncritically Ill Patients Hospitalized on Medical and Surgical Wards.Management of Inpatient Hyperglycemia and Diabetes in Older Adults.Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study)Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical ScenariosSystematic review of incretin therapy during peri-operative and intensive care
P2860
Q33792390-3724F3A5-6000-411E-AC4D-8BFE9D0E5A81Q35754150-B89169C7-198A-48C6-AE80-7C9D9371B431Q35912987-A7B8DB36-EB99-4F89-8BFD-7F897049737FQ36074125-02D00EB3-B620-4830-A47B-5B80D3339442Q36074155-75DB1D3A-7C03-4F55-81F8-A9DBC55E7318Q37683212-7B687AA5-5CDC-430F-8A49-730CF9D7123CQ37728282-667D457A-70A3-4274-8A4C-E533B9144C15Q38187004-4FD84CAF-ECB3-4143-A08D-16A30C4FEEF5Q38303079-1F18D264-8729-4CCD-B725-8BF2F1CF4F10Q38497683-5519B587-555C-4D1C-ACDE-CA584829E4EFQ38683079-903E6131-5EC7-4307-92B7-AED6183E2022Q38709346-547E848A-079D-4573-8B03-6FB632694C05Q38734956-2BFC1C19-C22E-4DC3-9419-C239990AA792Q38771951-5FCA0CBB-54CC-4325-9A2A-38EB8A19186FQ39218530-E3529DB5-B5EB-4AA4-922A-5E252C7C676AQ40081414-77536599-66F5-46C5-AD96-041159123E07Q42688784-DB77CF14-8B86-4FE1-A540-3D7B0F4FA26EQ43193460-4A960640-A826-432C-BADC-F6C415815EA8Q46031229-729820A8-9800-41BC-A3BD-C28B1943B5DDQ47113598-3F1EF690-A4B6-4991-990B-06AE1CB6E621Q47157137-B5A2E41C-4559-4CBC-B83F-B9AF69A75533Q47221869-1820349D-D1A2-4D90-9F03-97378C839A43Q47269489-6E263550-9D03-478E-9282-AB8FD739D071Q47666433-B3F6DAFF-033E-4626-8D5A-3094B149C755Q48070431-2DAE855B-6A05-4BFB-B6AB-EB295B95230DQ53753874-7C954728-1160-45E9-A278-3F60A05DD7F5Q54948267-984C2BF8-1074-48A2-81AA-40580BCFE7B8Q55033081-14D01A02-D24C-4004-97D3-456319309898Q58749756-2D53DE8F-740B-406D-9C9E-DCD5E50F004CQ58772421-0C8F0715-F363-470F-BFB8-E23DFF9E32C1Q59126600-4D781F4F-02B9-4BD9-B34E-632C5B4EDF02
P2860
Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and efficacy of sitagli ...... randomized, controlled study.
@en
Safety and efficacy of sitagli ...... randomized, controlled study.
@nl
type
label
Safety and efficacy of sitagli ...... randomized, controlled study.
@en
Safety and efficacy of sitagli ...... randomized, controlled study.
@nl
prefLabel
Safety and efficacy of sitagli ...... randomized, controlled study.
@en
Safety and efficacy of sitagli ...... randomized, controlled study.
@nl
P2093
P2860
P356
P1433
P1476
Safety and efficacy of sitagli ...... randomized, controlled study.
@en
P2093
Christopher Newton
David H Wesorick
David Reyes
Dawn Smiley
Farnoosh Farrokhi
Francisco Pasquel
Guillermo E Umpierrez
Limin Peng
Roma Gianchandani
Sangeeta Lathkar-Pradhan
P2860
P304
P356
10.2337/DC13-0277
P407
P577
2013-07-22T00:00:00Z